Therapeutics Bridge Labs (TxBL), launched by MSK in 2025 and embedded within OEC, represents a unique strategic asset among New York City academic research institutions.
We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results